Skip to main content
Equibles

Nuveen, LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1871926 CHARLOTTE, NC
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$89,325,625
+$41,253,696 QoQ
Shares Held
1,625,876
+12.4% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#15
of 426 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Nuveen, LLC holds $4,966,990,470 across 286 Biotechnology names. TGTX ranks #5 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,019,974 $1,259,534,587
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,081,685 $537,305,388
3 EXEL
Exelixis, Inc.
 3,276,984 $178,300,697
4 ALNY
Alnylam Pharmaceuticals, Inc.
 315,630 $95,014,096
5 TGTX
Tg Therapeutics, Inc.
This page 		1,625,876 $89,325,625
6 RVMD
Revolution Medicines, Inc.
 475,231 $89,001,259
7 JAZZ
Jazz Pharmaceuticals plc
 365,405 $88,051,641
8 ROIV
Roivant Sciences Ltd.
 1,970,504 $69,736,134

All Filings in TGTX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $89,325,625 1,625,876
2026-03-31 $48,071,929 1,447,078
2025-12-31 $28,415,069 953,206
2025-09-30 $25,676,637 710,772
2025-06-30 $23,650,935 657,153
2025-03-31 $29,442,222 746,696